Evidence map›Paper›PMID 28420840›Full record

ArticleInternal medicine (Tokyo, Japan)2017

Successful Long-term Management with a Single Administration of Tri-weekly Nab-paclitaxel in a Patient with Advanced Gastric Cancer with Peritoneal Dissemination.

Daisuke Matano, Toshikazu Moriwaki, Yoshitaka Tange, Yusuke Niisato, Masamichi Yamaura, Masaomi Nagase, Daisuke Suganuma, Kaoruko Takagi Taketa, Kentaro Iwai, Chiaki Enami and 2 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daisuke MatanoFaculty of Medicine, Division of Gastroenterology, University of Tsukuba, Japan.
Toshikazu MoriwakiFaculty of Medicine, Division of Gastroenterology, University of Tsukuba, Japan.
Yoshitaka TangeFaculty of Medicine, Division of Gastroenterology, University of Tsukuba, Japan.
Yusuke NiisatoFaculty of Medicine, Division of Gastroenterology, University of Tsukuba, Japan.
Masamichi YamauraFaculty of Medicine, Division of Gastroenterology, University of Tsukuba, Japan.
Masaomi NagaseFaculty of Medicine, Division of Gastroenterology, University of Tsukuba, Japan.
Daisuke SuganumaFaculty of Medicine, Division of Gastroenterology, University of Tsukuba, Japan.
Kaoruko Takagi TaketaFaculty of Medicine, Division of Gastroenterology, University of Tsukuba, Japan.
Kentaro IwaiFaculty of Medicine, Division of Gastroenterology, University of Tsukuba, Japan.
Chiaki EnamiFaculty of Medicine, Division of Gastroenterology, University of Tsukuba, Japan.
Yoshiyuki YamamotoFaculty of Medicine, Division of Gastroenterology, University of Tsukuba, Japan.
Ichinosuke HyodoFaculty of Medicine, Division of Gastroenterology, University of Tsukuba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticle albumin-bound (nab)-paclitaxel has shown promising activity in advanced gastric cancer treatment. We herein report a case of advanced gastric cancer involving long-term management with a single administration of nab-paclitaxel. A 71-year-old man diagnosed with advanced gastric cancer with malignant ascites was treated with nab-paclitaxel as a second-line chemotherapy. He refused treatment continuation because of various severe toxicities in the first treatment cycle; he was therefore followed-up without any further treatments. Despite this, no disease progression was observed over 9 months. After progression, he received dose-dense paclitaxel, but he did not respond to this treatment and eventually died.

Indexed as

AgedAlbuminsAntineoplastic Agents, PhytogenicAntineoplastic Combined Chemotherapy ProtocolsDrug Delivery SystemsFatal OutcomeHumansMaleNanoparticlesPaclitaxelPeritoneal NeoplasmsStomach Neoplasms130-nm albumin-bound paclitaxelAlbuminsAntineoplastic Agents, PhytogenicPaclitaxelascitesdisseminationgastric cancernab-paclitaxel

Identifiers

PMID28420840
PMCPMC5465408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.